EUVIMEDEUVIMED entdecken
Crossref

From Remission to Complication: Hemophagocytic Lymphohistiocytosis and Avascular Necrosis During Brentuximab Therapy in Hodgkin Lymphoma

Maram Badra, Abdulrahman Zaki, Nooran Soror, Reem Eshra, Ashraf Elghandour, Ahmed H Abdulfattah, Mohamed H Elbahoty

Cureus · 30.10.2026

DOI: 10.7759/cureus.118835 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 30.10.2026. Verfasst von Maram Badra und 6 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Badra, M., Zaki, A., Soror, N., Eshra, R., Elghandour, A., Abdulfattah, A. H., & Elbahoty, M. H. (2026). From Remission to Complication: Hemophagocytic Lymphohistiocytosis and Avascular Necrosis During Brentuximab Therapy in Hodgkin Lymphoma. Cureus. https://doi.org/10.7759/cureus.118835

Vancouver

Badra M, Zaki A, Soror N, Eshra R, Elghandour A, Abdulfattah AH, et al. From Remission to Complication: Hemophagocytic Lymphohistiocytosis and Avascular Necrosis During Brentuximab Therapy in Hodgkin Lymphoma. Cureus. 2026. doi:10.7759/cureus.118835

BibTeX
@article{Badra2026,
  author = {Badra, Maram and Zaki, Abdulrahman and Soror, Nooran and Eshra, Reem and Elghandour, Ashraf and Abdulfattah, Ahmed H and Elbahoty, Mohamed H},
  title = {From Remission to Complication: Hemophagocytic Lymphohistiocytosis and Avascular Necrosis During Brentuximab Therapy in Hodgkin Lymphoma},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.118835}
}
Kostenlos starten →